It has been proposed that diminished PACAP in AD would have a diminished neurotrophic role that would contribute to this disorder, as indicated by lower levels of PACAP in the CSF in AD patients (Han et al., 2014). Here, ADCYAP1 is linked to Alzheimer disease.